Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals

Bibliographic citation

J. Med. Chem. 2025, 68, 16, 17823–17839 https://doi.org/10.1021/acs.jmedchem.5c01558

Type of academic work

Academic degree

Abstract

[Abstract]Two decadentate acyclic chelators bearing four picolinic acid groups appended on either an ethylenediamine (H4TPAEN) or a trans-1,2-cyclohexyldiamine (H4TPADAC) unit were explored as candidates for lanthanum-based radiopharmaceutical development. The two chelators form ten-coordinated complexes with La3+ in the solid state, as evidenced by the corresponding X-ray structures and solution NMR studies. The La3+ complexes of TPAEN4– and TPADAC4– are characterized by high thermodynamic stability constants of log KLaL = 19.16(8) and 19.55(1), respectively. Kinetics studies indicate that the complexes dissociate following the acid-catalyzed and Cu2+-assisted pathways. Quantitative radiolabeling of both chelators with [135La]La3+ was achieved at pH ∼ 4–5 using straightforward protocols and low concentrations of the chelator (3 μM). Both in vitro and in vivo studies indicate that the [135La]La3+ complex of TPAEN4– is significantly more stable than the TPADAC4– analogue, with the former remaining intact and stable even after 60 min in vivo when injected to healthy mice

Description

Rights

© 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0
Attribution 4.0 International
© 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0

Except where otherwise noted, this item's license is described as © 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0